Partners
Partners
The Cordial project is carried out by the following partners:
UMC Utrecht uitklapper, klik om te openen
University Medical Center Utrecht (UMCU). The UMCU is a leading international academic medical center where knowledge of health, illness and care is generated, evaluated, shared and applied for the benefit of patients and society. The clinical demand of the patient - present and future - is the focal point of the ambition of the UMCU.One of the major goals of the UMCU is to translate results from laboratory research into new therapies for disease. Scientists pursuing basic research questions closely collaborate with clinicians involved in patient care, allowing the UMCU to remain at the forefront of new developments and to provide better care. A multidisciplinary approach guarantees patients’ benefit from the latest available expertise and innovative technological solutions. Interaction with patients and society creates an ‘innovation loop’ where societal issues guide scientific research and scientific results quickly move from bench to bedside and back.
UNIMORE uitklapper, klik om te openen
Universita degli studi di Modena e Reggio Emilia (UNIMORE). The University of Modena is one of the oldest Universities in Italy and ranked among the top 8 comprehensive Universities in Italy for its high level of research. The Department of Surgical, Medical, Dental and Morphological Sciences with interests in Transplant, Oncological and Regenerative Medicine has been recently created from unification of previous different Departments all of them enjoying national and international recognition and prestige. It is linked at the University Hospital of Modena and it is a point of excellence for its technological equipment and variety of services. The University Hospital is a teaching Hospital with 700 beds and 28.000 hospital admissions/year. The Nephrology Dialysis and Renal Transplantation Unit is deeply involved in clinical field with a catchment area of 450.000 inhabitants. The Unit is in charge of 350 patients on chronic HD, 65 on peritoneal dialysis and 150 on kidney transplantation; incident patients on chronic dialysis are 135/year. Patients on PD are home treated by CAPD and APD in the ratio 40% to 60%. UNIMORE will lead in WP4 the clinical protocols and the phase 1 clinical trial.
SERMAS uitklapper, klik om te openen
SERMAS Hospital La Paz (IdiPAZ). The IdiPAZ Institute for Health Research was created as a place for biomedical research, as a result of the relationship that has been forged over the years between La Paz University Hospital (HULP) and the Autonomous University of Madrid (UAM). This strategic alliance has enabled multidisciplinary teams belonging to the above institutions to be set up in order to take on joint research projects, making the most of the human and material research resources at their disposal and promoting fund raising for research. IdiPAZ manages all of the resources for research, development and innovation at the centre in order to contribute to the promotion and protection of the health of the population.
Nanodialysis uitklapper, klik om te openen
Nanodialysis is a medical device company that specializes in blood purification. Main activity is the development and commercialization of a wearable/portable artificial kidney. Core technology for purification is the use of sorbents based on nanomaterials and the use of electro-oxidation. Nanomaterials are crucial as these materials provide both the necessary sorption capacity (high specific surface area) and selectivity (nanostructured pore size, surface chemical tuning). The concept of selective adsorption has been translated to a sorption filter unit used in a miniaturized, portable/portable dialysis machine. Nanodialysis has broad knowledge of methods for the removal of toxins, design and development of wearable/portable dialysis equipment and knowledge of market volume and mechanisms for kidney and CHF patients.
PPi HC Ltd uitklapper, klik om te openen
PPi HC Ltd is a pharmaceutical pricing, reimbursement (P&R) and market access specialist comprising an international network of country-based experts, each intimate with their respective healthcare systems and very familiar with commercialisation issues for pharmaceutical products. Pricing and reimbursement processes differ from country to country. PPi HC members are based in many global markets, have extensive knowledge and experience regarding their local market. PPi HC partners all have 20+ years’ experience.
